Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

In this case study, a 38-year-old woman with alopecia areata experienced significant improvement in hair regrowth after treatment with rakthamokshana and a herbal lepa containing Shodita Kasisa and Triphala masi mixed with nilibringaraj taila.

In this case report, an 18-year-old male with alopecia areata showed significant hair regrowth after six weekly treatments with Pracchana, accompanied by the external application of Indraluptha mashi and Malathyadi kera, suggesting these interventions may be effective for managing spot baldness.

This review discusses Ayurvedic perspectives on Polycystic Ovarian Syndrome and highlights correlations with traditional concepts like Nashtarthava, but reports no new clinical findings.

In this article, the authors discuss Ayurvedic concepts and treatments for Indralupta (Alopecia Areata), highlighting a case successfully managed with Ayurvedic medicine, while contrasting it with modern therapies like corticosteroids and immunosuppressants, which have significant side effects.

In this case study, researchers observed that Ayurvedic treatments, specifically Praccahnna and Tikta Patola patra swarasa Lepa, improved symptoms of alopecia areata, such as reducing patch size and hair fall.

In this case study, a 16-year-old boy with alopecia areata experienced complete hair regrowth after 4 months of Ayurvedic treatments, including Shamana Chikitsa and Raktamokshna, with no adverse effects reported.

In this study, a case of alopecia areata was successfully treated using Ayurvedic medicine, highlighting its potential as an alternative to corticosteroids and immunosuppressants, which can have serious adverse effects with prolonged use.

This study reports that the DMI3 gene, essential for nodule formation in legume-rhizobial symbiosis, encodes a calcium/calmodulin-dependent protein kinase, highlighting its role in multiple plant symbioses.

This review discusses the relationship between polycystic ovary syndrome and inflammation, highlighting various inflammatory markers, but reports no new clinical results.

In this study, topical tofacitinib significantly increased hair regrowth in mice compared to minoxidil or vehicle, potentially due to elevated VEGF levels and reduced inflammation.

In this case report, a 28-year-old woman developed a rash on her face and neck after receiving a dupilumab injection for atopic dermatitis.

This study found that a green-light LED microneedle patch enhanced hair growth in mice with the best results among tested wavelengths, showing increased hair follicles and no serious side effects, suggesting its potential for treating androgenetic alopecia.

In this study, 62.7% of patients with alopecia areata had deficient vitamin D levels, yet there was no significant link between these levels and specific alopecia areata patterns.

This study compared RNA-seq results from horse plucked-hair and skin-biopsy samples, finding that plucked hairs were enriched with hair-follicle keratinocytes, while biopsies showed enrichment for other cell types.

This study found that cutaneous manifestations are prevalent in PCOS patients, with 68% experiencing symptoms like hirsutism and acne, highlighting the need for better awareness across medical specialties.

The researchers reported that topical tofacitinib in mice increased hair follicles in the growth phase and boosted noggin and BMP4 mRNA expressions, compared to a vehicle and minoxidil.

This article discusses the teratogenic risks of skin condition treatments for individuals with DSD and notes that testosterone replacement, often used in this population, may cause acne.

This article discusses the dermatologic impacts of gender-affirming medical care in transgender adolescents and emphasizes the importance of patient-centered care to improve dermatologic and overall outcomes; it reports no new clinical results.

In this study, clinicians in Riyadh, Saudi Arabia, most commonly reported using a blended consultation model, which combines elements from various approaches to enhance doctor-patient interactions.

In this study, Makarova et al. found that topical vitamin D3 significantly delayed basal cell carcinoma development in UVR-exposed, BCC-prone mice, while oral vitamin D3 supplements did not prevent carcinogenesis, suggesting a potential role of UV-induced vitamin D3 in inhibiting tumor growth.

In this study, researchers found distinct gene expression patterns in Standardbred trotters capable of racing barefoot, suggesting a genetic basis for hoof strength and identifying specific genes involved in hoof biology, which could enhance equine performance and wellbeing through targeted genetic research.

In this study, topical and intralesional vitamin D3 and its analogs were found to be effective and safe treatments for mild-to-moderate alopecia areata, achieving a 53.75% success rate, though intralesional vitamin D3 was less effective than other treatments like corticosteroids.

This study found distinct proteomic differences between male and female androgenetic alopecia, highlighting sex-specific molecular pathways and potential biomarkers for pattern hair loss.

This study in Saudi Arabia found that 55.9% of participants reported premature graying of hair before age 30, with risk factors including genetic, health, and lifestyle aspects such as smoking, anxiety, nutrient deficiencies, and family history.

This study suggests an association between metabolic syndrome and androgenic alopecia severity, though this association was not statistically significant.

A Toy Poodle with hair loss regrew hair after being treated with melatonin and finasteride.

This review discusses the effectiveness of various treatments for reducing the size and number of facial pores and highlights the benefits of using combination therapies, reporting no new clinical results.

This study demonstrated that genetic markers can predict human ear morphology with moderate to good accuracy, potentially aiding forensic identification in crime scene investigations where traditional DNA matches are unavailable.

Atopic dermatitis severity doesn't worsen during pregnancy for most women.